Repurposing of FDA approved drugs
Molecular Digital Surveillance
Rapid and Cheap Diagnostic Kit
New Therapies/Drug Repurposing
Hospital Assisted Devices
Myths & Truths
Nanotechnology in prevention of infectitous diseases
Nanotechnology holds great promise in offering innovative solutions to a wide range of problems regarding the prevention, diagnosis, and treatment of COVID-19, in which nanotechnologists undoubtedly play a key role and shoulder their social responsibility. This webpage covers the most recent advances of nanotechnology in fighting COVID-19.
This web link tries to include all the aspects where nanotechnology is used in fighting against the pandemic COVID 19. Nanogold test, Nanofiltered face mask, anticoronavirus spray etc are included here.
Ministry of Health and Family Welfare (MoHFW) is an Indian government ministry charged with health policy in India . MoHFW in this link gives India’s updated number of active, cured/discharged death and migrated cases of COVID-19. This also gives the all the latest updates of COVID-19, state wise status, each district reporting and awareness notes.
Chloroquine — an approved malaria drug — is known in nanomedicine research for the investigation of nanoparticle uptake in cells, and may have potential for the treatment of COVID-19
The nanotechnology community can contribute significantly in the fight against COVID-19. Nanomaterials have been used for the development of point-of-care diagnostics, carriers for therapeutics, and vaccine development. Here a number of research targets for the nanotechnology community is recommended.
This study addresses developing novel charged PVDF nanofiber filter technology to effectively capture the deadly airborne coronavirus with our target set at 100nm (nano-aerosol), and not 300nm. PVDF nanofibers were produced with fiber diameters 84, 191, 349 and 525nm with excellent morphology. The fibers were subsequently charged by corona discharge.
The interaction of nanostructures with microorganisms is fast-revolutionizing the biomedical field by offering advantages in both diagnostic and therapeutic applications. Nanoparticles offer unique physical properties that have associated benefits for drug delivery. This review presents a broad overview of the application of nanosized materials for the treatment of common viral infections.
Arboviruses such as yellow fever, dengue, chikungunya and zika are transmitted mainly by the mosquito vector Aedes aegypti. In this review, the utilization of nano-based formulations on control and diagnosis of mosquito-borne diseases were discussed.
Various forms of nanocarriers, such as nanoparticles (polymeric, inorganic, and solid lipid), liposomes, polymeric micelles, dendrimers, cyclodextrins, and cell-based nanoformulations have been studied for delivery of drugs intended for HIV prevention or therapy. The aim of this review is to provide a summary of the application of nanocarrier systems to the delivery of anti-HIV drugs, specifically antiretrovirals.
Here it is discussed how biomaterials and specifically nanoscale delivery vehicles can be used to modify and improve the immune system response against infectious diseases. Nanoscale vehicles are particularly adapt at facilitating immunotherapeutic approaches because they can be engineered to have different physical properties, encapsulated agents, and surface ligands.
It is a review on recent progress in biomimetic and bioengineered nanotherapies for the treatment of infectious disease. Different biomimetic nanoparticles, derived from viruses, bacteria, and mammalian cells, are first described, with respect to their construction and biophysicochemical properties. Then, the applications of diverse biomimetic nanoparticles in anti-infective therapy are introduced, either by their intrinsic activity or by loading and sitespecifically delivering various molecular drugs.
This review summarizes the current progress in the use of nanotechnology for the development of an HIV/AIDS vaccine and discuss its potential to greatly improve the solubility, permeability, stability and pharmacokinetics of HIV vaccines.Nanomaterials such as inorganic nanomaterials, Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a contingency of scientists that are contributing ideas and technology to the Centers for Disease Control and Prevention to fight the COVID-19 outbreak. This link gives brief idea about how Webster is proposing particles of similar sizes that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment. That structural change would then halt the ability of the virus to survive and reproduce in the body.
Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a contingency of scientists that are contributing ideas and technology to the Centers for Disease Control and Prevention to fight the COVID-19 outbreak. This link gives brief idea about how Webster is proposing particles of similar sizes that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment. That structural change would then halt the ability of the virus to survive and reproduce in the body.
Conventional vaccine methods to elicit immune responses have limitations in effectively controlling new and re-merging pathogens. Nanoparticle-based vaccines show promise in overcoming these limitations due to their versatility and tunability to protect antigen from premature degradations, facilitate their intracellular uptakes and elicit prolonged immunity against infectious diseases.This review will focus on the different type of organic and inorganic nanoparticles used as vaccine against infectious diseases.
Copyright CSIR-NEIST, Jorhat-6, Assam. All Rights Reserved